Full Guilty-Plea Credit Where Administrative Charging Issues Delay the First Reasonable Opportunity to Plead

Case: R v Hollywood [2026] EWCA Crim 558
Court: Court of Appeal (Criminal Division) (Lord Justice Dove, Mr Justice Soole, HHJ Edmunds KC)
Date: 24 April 2026
Appeal from: Crown Court at York (HHJ Hickey)

1. Introduction

This sentence appeal concerned Class A drug offending involving Nitazene (a synthetic opioid). The appellant pleaded guilty in the Crown Court to three counts of possession of a Class A drug with intent, contrary to section 5(3) Misuse of Drugs Act 1971, arising from seizures on three dates in January 2025 at different locations.

The central issue on appeal was not the seriousness of the offending as such, but the correct application of guilty-plea credit where (as the defence argued) there was no earlier procedurally realistic opportunity to plead to Nitazene offences because the Magistrates’ Court proceedings recorded that the Nitazene-related charge was “withdrawn in favour of another offence” amid administrative/coding confusion.

2. Summary of the Judgment

• The Court of Appeal rejected challenges to the sentencing judge’s approach to harm categorisation and to the overall severity of the sentence (once totality was properly understood).
• The Court of Appeal allowed the appeal on guilty-plea credit: the appellant was entitled to the full one-third reduction because the first reasonable opportunity to plead to the Nitazene charges did not arise until the Crown Court hearing on 3 April 2025, when the final indictment containing the Nitazene counts (including the most serious count) was put.
• The overall sentence was reduced from 11 years to 9 years 9 months imprisonment, with concurrent reductions on the other counts.

3. Key Facts (Condensed)

Count 1 (6 January 2025)

• Search at an address in Scarborough found Nitazene tablets (marked “Xanax”), loose powder, and substantial pill-pressing/manufacturing paraphernalia.
• Phone material was consistent with drug supply.

Count 2 (22 January 2025)

• Search at another address found similar paraphernalia and 933 Nitazene tablets (around 397g).
• The appellant was remanded to appear before the Magistrates’ Court on 24 January 2025.

Magistrates’ Court hearing (24 January 2025): charging/coding confusion

• No IDPC had been provided at that stage.
• The “Court Extract” recorded various PWITS charges but noted the Nitazene-related Class A entry as “withdrawn in favour of another offence”.
• Administrative notes later referred to difficulty identifying the correct charging code for Nitazene, and the apparent use of a cocaine code.

Count 3 (27 January 2025)

• A storage unit rented by the appellant contained 2.86kg of Nitazene powder, capable of producing thousands of tablets.

Pleas and sentence

• On 3 April 2025, when the final indictment (dated 17 March 2025) was put, the appellant pleaded guilty to counts 1–3; remaining counts lay on the file.
• On 17 June 2025, the Crown Court imposed a total of 11 years (concurrent sentences), applying 25% guilty-plea credit rather than one-third.

4. Analysis

A. Precedents and Authorities Cited

B. Legal Reasoning

(1) Role, harm and starting point: no material error

The sentencing judge treated count 3 (2.86kg Nitazene powder) as the lead offence. He assessed the appellant as acting in a leading role, describing him as the “main man” operating across three properties with close source links and no claim of duress or subordination. On harm, the judge located the quantity “somewhere between category 1 and category 2”, but explicitly based sentence on category 2 and moved up the starting point from 11 to 12 years.

The Court of Appeal found no error: the judge did not misclassify harm as category 1; rather he adopted category 2 with a justified upward adjustment reflecting quantity and the particular dangers associated with Nitazene.

(2) The uplift to reflect other counts and aggravation: not manifestly excessive

The judge increased the figure to reflect (i) the additional offending in counts 1 and 2 (to be sentenced concurrently but still relevant to overall seriousness), and (ii) aggravating features, including substantial prior drug convictions and commission of count 2 while on bail. The defence argued the resultant pre-credit figure (described by the judge as 16 years before plea credit) was too high for drug type/quantity.

The Court of Appeal rejected that characterisation. It emphasised that the “16 years” was not a sentence for count 3 in isolation; it was the composite assessment taking account of the overall criminality across all three counts and aggravation. It also endorsed the judge’s emphasis on Nitazene’s harmfulness as a cutting agent increasing lethality.

(3) Totality: the effective pre-credit figure was lower than it appeared

The Court highlighted an important practical point: the judge later reduced the overall term by one year for totality. Although that reduction could have been made earlier in the arithmetic, its effect was that the judge’s true overall pre-credit assessment was effectively 14 years 8 months, not 16 years. That reframing mattered when assessing whether the sentence was “manifestly excessive”; on the facts (three sizeable episodes, leading role, previous convictions, bail aggravation), it was not.

(4) Guilty-plea credit: “first reasonable opportunity” was when Nitazene charges were actually available

This was the decisive error below. The Crown Court treated the appellant as having missed an earlier opportunity to plead, pointing to the Better Case Management form (“Capable of resolution but not today”) and viewing the earlier issues as mere administrative/coding difficulty.

The Court of Appeal disagreed on principle and on the record:

• On 24 January 2025, there was no Nitazene charge before the Magistrates’ Court; the Court Extract recorded the Nitazene entry as “withdrawn in favour of another offence”.
• The only Class A charge then identified was cocaine.
• Count 3 (the most serious Nitazene count) post-dated that Magistrates’ Court hearing and only appeared later on the final indictment.

Accordingly, whatever administrative difficulty existed, the appellant did not have a reasonable opportunity to plead guilty to Nitazene offences until 3 April 2025, when the final indictment containing those counts was put. Full one-third credit should therefore have been applied.

C. Disposition and Recalculated Sentences

Applying full one-third credit to the effective overall pre-credit figure (14 years 8 months), with rounding down, the Court substituted:

• Count 3: reduced from 11 years to 9 years 9 months (overall term);
• Count 1: reduced from 6 years to 5 years 4 months (concurrent);
• Count 2: reduced from 6 years 9 months to 6 years (concurrent).

D. Impact

• Fairness in plea credit where charging is defective or unavailable: Defendants should not lose the full one-third discount because of prosecution/court administrative failures, coding errors, or the absence of an available charge. The key question is the first reasonable opportunity to plead to the relevant offence.
• Record-keeping and clarity at early hearings: The decision underscores the importance of accurate Magistrates’ Court records (including “withdrawn” entries) and of prompt, correct charging where novel or unusually coded substances are involved.
• Sentencing methodology transparency: The Court’s treatment of “effective” pre-credit figures and totality shows the appellate focus on what the sentencing judge substantively did, not merely the intermediate arithmetic labels.

5. Complex Concepts Simplified

• “First reasonable opportunity” (guilty-plea credit): The earliest stage when the defendant can realistically plead guilty to the actual offence charged. If the offence is not yet charged (or is recorded as withdrawn), the opportunity has not arisen.
• Concurrent sentences: Sentences served at the same time. Even when concurrent, additional counts can still justify an uplift in the lead sentence because they increase overall criminality.
• Totality: A final check that the overall sentence for multiple offences is just and proportionate, avoiding double counting and ensuring the total reflects overall wrongdoing.
• Role and harm categories (drug guidelines): Sentencing commonly turns on (i) the offender’s role (leading/significant/lesser) and (ii) harm, often linked to drug quantity and context; judges then adjust for aggravating/mitigating factors.

6. Conclusion

R v Hollywood confirms that full one-third guilty-plea credit must be granted where administrative or charging/coding issues mean the defendant had no earlier reasonable opportunity to plead to the offence ultimately pursued. While the Court upheld the sentencing judge’s assessment of seriousness (role, harm, aggravation and totality), it corrected a principle-based error on plea credit, reducing the overall term to 9 years 9 months.